Crystal Structure of Human CD47 in Complex with Engineered SIRP[alpha].D1(N80A)

Yu, Jifeng; Li, Song; Chen, Dianze; Liu, Dandan; Guo, Huiqin; Yang, Chunmei; Zhang, Wei; Zhang, Li; Zhao, Gui; Tu, Xiaoping; Peng, Liang; Liu, Sijin; Bai, Xing; Song, Yongping; Jiang, Zhongxing; Zhang, Ruliang; Tian, Wenzhi

doi:10.3390/molecules27175574

Crystal Structure of Human CD47 in Complex with Engineered SIRP[alpha].D1(N80A)

Journal Article · 01 August 2022 · Molecules

DOI:https://doi.org/10.3390/molecules27175574· OSTI ID:1901174

Yu, Jifeng; Li, Song; Chen, Dianze; Liu, Dandan; Guo, Huiqin; Yang, Chunmei; Zhang, Wei; Zhang, Li; Zhao, Gui; Tu, Xiaoping; Peng, Liang; Liu, Sijin; Bai, Xing; Song, Yongping; Jiang, Zhongxing; Zhang, Ruliang; Tian, Wenzhi

Research Organization:: Advanced Photon Source (APS), Argonne National Laboratory (ANL), Argonne, IL (US)

Sponsoring Organization:: DOE - Office Of Science; OTHER

OSTI ID:: 1901174

Journal Information:: Molecules, Journal Name: Molecules Journal Issue: (17) Vol. 27

Country of Publication:: United States

Language:: ENGLISH

References (31)

Structural analysis and binding sites of inhibitors targeting the CD47/SIRPα interaction in anticancer therapy Huang, Bo; Bai, Zhaoshi; Ye, Xinyue Computational and Structural Biotechnology Journal, Vol. 19 https://doi.org/10.1016/j.csbj.2021.09.036	journal	January 2021
The CD47-SIRPα Immune Checkpoint Logtenberg, Meike E. W.; Scheeren, Ferenc A.; Schumacher, Ton N. Immunity, Vol. 52, Issue 5 https://doi.org/10.1016/j.immuni.2020.04.011	journal	May 2020
Targeting CD47 for cancer immunotherapy Jiang, Zhongxing; Sun, Hao; Yu, Jifeng Journal of Hematology & Oncology, Vol. 14, Issue 1 https://doi.org/10.1186/s13045-021-01197-w	journal	October 2021
Glutaminyl cyclase is an enzymatic modifier of the CD47- SIRPα axis and a target for cancer immunotherapy Logtenberg, Meike E. W.; Jansen, J. H. Marco; Raaben, Matthijs Nature Medicine, Vol. 25, Issue 4 https://doi.org/10.1038/s41591-019-0356-z	journal	March 2019
CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer Weiskopf, Kipp; Jahchan, Nadine S.; Schnorr, Peter J. Journal of Clinical Investigation, Vol. 126, Issue 7 https://doi.org/10.1172/JCI81603	journal	June 2016
CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s Lymphoma Advani, Ranjana; Flinn, Ian; Popplewell, Leslie New England Journal of Medicine, Vol. 379, Issue 18 https://doi.org/10.1056/NEJMoa1807315	journal	November 2018
Current Advancements in Addressing Key Challenges of Therapeutic Antibody Design, Manufacture, and Formulation Sifniotis, Vicki; Cruz, Esteban; Eroglu, Barbaros Antibodies, Vol. 8, Issue 2 https://doi.org/10.3390/antib8020036	journal	June 2019
Paired Receptor Specificity Explained by Structures of Signal Regulatory Proteins Alone and Complexed with CD47 Hatherley, Deborah; Graham, Stephen C.; Turner, Jessie Molecular Cell, Vol. 31, Issue 2 https://doi.org/10.1016/j.molcel.2008.05.026	journal	July 2008
Recent Advances of Tumor Therapy Based on the CD47-SIRPα Axis Wang, Yuchen; Zhao, Chenxuan; Liu, Yang Molecular Pharmaceutics, Vol. 19, Issue 5 https://doi.org/10.1021/acs.molpharmaceut.2c00073	journal	April 2022
A SIRPα‐Fc fusion protein enhances the antitumor effect of oncolytic adenovirus against ovarian cancer Huang, Yao; Lv, Sai‐qun; Liu, Pin‐yi Molecular Oncology, Vol. 14, Issue 3 https://doi.org/10.1002/1878-0261.12628	journal	February 2020
The Structure of the Macrophage Signal Regulatory Protein α (SIRPα) Inhibitory Receptor Reveals a Binding Face Reminiscent of That Used by T Cell Receptors Hatherley, Deborah; Harlos, Karl; Dunlop, D. Cameron Journal of Biological Chemistry, Vol. 282, Issue 19 https://doi.org/10.1074/jbc.M611511200	journal	March 2007
Functional characterization of the selective pan-allele anti-SIRPα antibody ADU-1805 that blocks the SIRPα–CD47 innate immune checkpoint Voets, Erik; Paradé, Marc; Lutje Hulsik, David Journal for ImmunoTherapy of Cancer, Vol. 7, Issue 1 https://doi.org/10.1186/s40425-019-0772-0	journal	December 2019
Anti-leukemic activity and tolerability of anti-human CD47 monoclonal antibodies Pietsch, E. C.; Dong, J.; Cardoso, R. Blood Cancer Journal, Vol. 7, Issue 2 https://doi.org/10.1038/bcj.2017.7	journal	February 2017
The CCP4 suite programs for protein crystallography No authors listed Acta Crystallographica Section D Biological Crystallography, Vol. 50, Issue 5, p. 760-763 https://doi.org/10.1107/S0907444994003112	journal	September 1994
Antibody stability: A key to performance - Analysis, influences and improvement Ma, Hui; Ó’Fágáin, Ciarán; O’Kennedy, Richard Biochimie, Vol. 177 https://doi.org/10.1016/j.biochi.2020.08.019	journal	October 2020
Polymorphisms in the Human Inhibitory Signal-regulatory Protein α Do Not Affect Binding to Its Ligand CD47 Hatherley, Deborah; Lea, Susan M.; Johnson, Steven Journal of Biological Chemistry, Vol. 289, Issue 14 https://doi.org/10.1074/jbc.M114.550558	journal	February 2014
Targeting CD47/SIRPα as a therapeutic strategy, where we are and where we are headed Qu, Tailong; Li, Baiyong; Wang, Yifei Biomarker Research, Vol. 10, Issue 1 https://doi.org/10.1186/s40364-022-00373-5	journal	April 2022
First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers Sikic, Branimir I.; Lakhani, Nehal; Patnaik, Amita Journal of Clinical Oncology, Vol. 37, Issue 12 https://doi.org/10.1200/JCO.18.02018	journal	April 2019
Engineered SIRPα Variants as Immunotherapeutic Adjuvants to Anticancer Antibodies Weiskopf, Kipp; Ring, Aaron M.; Ho, Chia Chi M. Science, Vol. 341, Issue 6141 https://doi.org/10.1126/science.1238856	journal	May 2013
Clinicopathological and Prognostic Significance of CD47 Expression in Lung Neuroendocrine Tumors Orozco-Morales, Mario; Avilés-Salas, Alejandro; Hernández-Pedro, Norma Journal of Immunology Research, Vol. 2021 https://doi.org/10.1155/2021/6632249	journal	June 2021
Novel SIRPα Antibodies That Induce Single-Agent Phagocytosis of Tumor Cells while Preserving T Cells Andrejeva, Gabriela; Capoccia, Benjamin J.; Hiebsch, Ronald R. The Journal of Immunology, Vol. 206, Issue 4 https://doi.org/10.4049/jimmunol.2001019	journal	January 2021
Coot model-building tools for molecular graphics Emsley, Paul; Cowtan, Kevin Acta Crystallographica Section D Biological Crystallography, Vol. 60, Issue 12, p. 2126-2132 https://doi.org/10.1107/S0907444904019158	journal	November 2004
Progress of CD47 immune checkpoint blockade agents in anticancer therapy: a hematotoxic perspective Chen, Yu-Chi; Shi, Wei; Shi, Jia-Jie Journal of Cancer Research and Clinical Oncology, Vol. 148, Issue 1 https://doi.org/10.1007/s00432-021-03815-z	journal	October 2021
A SIRPαFc Fusion Protein Conjugated With the Collagen-Binding Domain for Targeted Immunotherapy of Non-Small Cell Lung Cancer Liu, Jiayang; Meng, Zhefeng; Xu, Tongyang Frontiers in Immunology, Vol. 13 https://doi.org/10.3389/fimmu.2022.845217	journal	March 2022
Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells Takenaka, Katsuto; Prasolava, Tatiana K.; Wang, Jean C. Y. Nature Immunology, Vol. 8, Issue 12 https://doi.org/10.1038/ni1527	journal	November 2007
Identification of Glutaminyl Cyclase isoenzyme isoQC as a regulator of SIRPα-CD47 axis Wu, Zhiqiang; Weng, Linjun; Zhang, Tengbo Cell Research, Vol. 29, Issue 6 https://doi.org/10.1038/s41422-019-0177-0	journal	May 2019
Risk-Adapted, Individualized Treatment Strategies of Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML) Bewersdorf, Jan Philipp; Zeidan, Amer M. Cancers, Vol. 13, Issue 7 https://doi.org/10.3390/cancers13071610	journal	March 2021
How good are my data and what is the resolution? Evans, Philip R.; Murshudov, Garib N. Acta Crystallographica Section D Biological Crystallography, Vol. 69, Issue 7 https://doi.org/10.1107/S0907444913000061	journal	June 2013
Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants Kabsch, W. Journal of Applied Crystallography, Vol. 26, Issue 6 https://doi.org/10.1107/S0021889893005588	journal	December 1993
Antibody disulfide bond reduction and recovery during biopharmaceutical process development—A review Ren, Tingwei; Tan, Zhijun; Ehamparanathan, Vivekh Biotechnology and Bioengineering, Vol. 118, Issue 8 https://doi.org/10.1002/bit.27790	journal	June 2021
SIRPα-αCD123 fusion antibodies targeting CD123 in conjunction with CD47 blockade enhance the clearance of AML-initiating cells Tahk, Siret; Vick, Binje; Hiller, Björn Journal of Hematology & Oncology, Vol. 14, Issue 1 https://doi.org/10.1186/s13045-021-01163-6	journal	September 2021

Similar Records

Crystal structure of the human PRMT5:MEP50 complex

Journal Article · 2013 · Proc. Natl. Acad. Sci. USA · OSTI ID:1064472

Crystal structure of dopamine D1 receptor in complex with G protein and a non-catechol agonist

Journal Article · 2021 · Nat. Commun. · OSTI ID:1834916

Crystal structure of dopamine D1 receptor in complex with G protein and a non-catechol agonist

Journal Article · 2021 · Nat. Commun. · OSTI ID:1831191

Crystal Structure of Human CD47 in Complex with Engineered SIRP[alpha].D1(N80A)

Citation Formats

References (31)

Similar Records

Related Subjects